Abiopharma

Clinical trial NCT06597734 updates: 1. completion date: 2029-08-31 → 2026-06-11 2. primary completion date: 2027-08-31 → 2026-06-11

Clinical trial NCT06052631: start date: 2026-06-18 → 2026-06-21.

Clinical trial NCT06317220: primary completion date: 2025-12-01 → 2026-02-17.

Clinical trial NCT06832618 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 240 → 159 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05159388 updates: 1. status: COMPLETED → TERMINATED 2. completion date: 2025-04-08 → 2025-04-01 3. primary completion date: 2025-04-08 → 2025-04-01 4. enrollment: 45 → 46 participants

Clinical trial NCT05630859: enrollment: 1004 → 1009 participants.

Clinical trial NCT06977438 updates: 1. start date: 2027-01-01 → 2026-10-01 2. masking: NONE → TRIPLE

Clinical trial NCT07108894: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT06812247 updates: 1. completion date: 2026-06-01 → 2026-12-01 2. primary completion date: 2026-06-01 → 2026-12-01

Clinical trial NCT06106308: enrollment: 113 → 110 participants.